stockrowLabcorp Holdings Inc.
LH Healthcare Diagnostics & Research
Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024.
- Revenue
- +6.92%
- EPS
- +3.32%
- Free cash flow
- +44.7%
- Total debt
- +3.21%
Quarter to September 2026, against a year earlier
Follow LH
Alert me
Labcorp Holdings Inc. (LH) Total debt
Labcorp Holdings Inc.'s total debt at the end of fiscal 2025 was $5.1B, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $5.3B. Over the past ten years it has ranged from $4.1B (fiscal 2023) to $6.3B (fiscal 2017); the current reading is higher than 27% of that period. Labcorp Holdings Inc. ranks 5th of 46 Diagnostics & Research companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $5.1B | (4.77%) |
| FY2024 | $5.4B | 30.78% |
| FY2023 | $4.1B | (19.31%) |
| FY2022 | $5.1B | (6.88%) |
| FY2021 | $5.5B | (0.04%) |
| FY2020 | $5.5B | (6.42%) |
| FY2019 | $5.9B | (2.66%) |
| FY2018 | $6.0B | (4.77%) |
| FY2017 | $6.3B | 19.71% |
| FY2016 | $5.3B | (10.78%) |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $5.3B | (10.26%) |
| Jun 2026 | $5.9B | 0.40% |
| Mar 2026 | $5.9B | 14.54% |
| Dec 2025 | $5.1B | 0.02% |
| 43 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| IQV IQVIA Holdings Inc. compare | $16.1B |
| DGX Quest Diagnostics Incorporated compare | $5.6B |
| LH Labcorp Holdings Inc. | $5.3B |
| WAT Waters Corporation compare | $4.9B |
| A Agilent Technologies, Inc. compare | $3.6B |
| MTD Mettler-Toledo International, Inc. compare | $2.1B |
| ILMN Illumina, Inc. compare | $1.8B |
| GH Guardant Health, Inc. compare | $1.5B |
| MEDP Medpace Holdings, Inc. compare | $163.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on LH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement